Renal Drugs Market, Global Outlook and Forecast 2022-2028

July 2024 | 66 pages | ID: R5E32A023FECEN
Market Monitor Global

Abstracts

Renal diseases are becoming a significant health issue among the general population. Renal drugs are majorly used for kidney disease treatment.

This report contains market size and forecasts of Renal Drugs in Global, including the following market information:

Global Renal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Renal Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Renal Drugs include Mylan, Roche Holding, Endo International, Bausch Health Companies, Apotex, Cardinal Health, Fresenius and Dava Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Renal Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Renal Drugs Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injections

Global Renal Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Renal Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacies
• Drug Stores
• Online Pharmacy
• Others

Global Renal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Renal Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Renal Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Renal Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Mylan
• Roche Holding
• Endo International
• Bausch Health Companies
• Apotex
• Cardinal Health
• Fresenius
• Dava Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Renal Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Renal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RENAL DRUGS OVERALL MARKET SIZE

2.1 Global Renal Drugs Market Size: 2021 VS 2028
2.2 Global Renal Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Renal Drugs Players in Global Market
3.2 Top Global Renal Drugs Companies Ranked by Revenue
3.3 Global Renal Drugs Revenue by Companies
3.4 Top 3 and Top 5 Renal Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Renal Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Renal Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Renal Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Renal Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Renal Drugs Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injections
4.2 By Type - Global Renal Drugs Revenue & Forecasts
  4.2.1 By Type - Global Renal Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Renal Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Renal Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Renal Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacies
  5.1.4 Drug Stores
  5.1.5 Online Pharmacy
  5.1.6 Others
5.2 By Application - Global Renal Drugs Revenue & Forecasts
  5.2.1 By Application - Global Renal Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Renal Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Renal Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Renal Drugs Market Size, 2021 & 2028
6.2 By Region - Global Renal Drugs Revenue & Forecasts
  6.2.1 By Region - Global Renal Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Renal Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Renal Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Renal Drugs Revenue, 2017-2028
  6.3.2 US Renal Drugs Market Size, 2017-2028
  6.3.3 Canada Renal Drugs Market Size, 2017-2028
  6.3.4 Mexico Renal Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Renal Drugs Revenue, 2017-2028
  6.4.2 Germany Renal Drugs Market Size, 2017-2028
  6.4.3 France Renal Drugs Market Size, 2017-2028
  6.4.4 U.K. Renal Drugs Market Size, 2017-2028
  6.4.5 Italy Renal Drugs Market Size, 2017-2028
  6.4.6 Russia Renal Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Renal Drugs Market Size, 2017-2028
  6.4.8 Benelux Renal Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Renal Drugs Revenue, 2017-2028
  6.5.2 China Renal Drugs Market Size, 2017-2028
  6.5.3 Japan Renal Drugs Market Size, 2017-2028
  6.5.4 South Korea Renal Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Renal Drugs Market Size, 2017-2028
  6.5.6 India Renal Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Renal Drugs Revenue, 2017-2028
  6.6.2 Brazil Renal Drugs Market Size, 2017-2028
  6.6.3 Argentina Renal Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Renal Drugs Revenue, 2017-2028
  6.7.2 Turkey Renal Drugs Market Size, 2017-2028
  6.7.3 Israel Renal Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Renal Drugs Market Size, 2017-2028
  6.7.5 UAE Renal Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Mylan
  7.1.1 Mylan Corporate Summary
  7.1.2 Mylan Business Overview
  7.1.3 Mylan Renal Drugs Major Product Offerings
  7.1.4 Mylan Renal Drugs Revenue in Global Market (2017-2022)
  7.1.5 Mylan Key News
7.2 Roche Holding
  7.2.1 Roche Holding Corporate Summary
  7.2.2 Roche Holding Business Overview
  7.2.3 Roche Holding Renal Drugs Major Product Offerings
  7.2.4 Roche Holding Renal Drugs Revenue in Global Market (2017-2022)
  7.2.5 Roche Holding Key News
7.3 Endo International
  7.3.1 Endo International Corporate Summary
  7.3.2 Endo International Business Overview
  7.3.3 Endo International Renal Drugs Major Product Offerings
  7.3.4 Endo International Renal Drugs Revenue in Global Market (2017-2022)
  7.3.5 Endo International Key News
7.4 Bausch Health Companies
  7.4.1 Bausch Health Companies Corporate Summary
  7.4.2 Bausch Health Companies Business Overview
  7.4.3 Bausch Health Companies Renal Drugs Major Product Offerings
  7.4.4 Bausch Health Companies Renal Drugs Revenue in Global Market (2017-2022)
  7.4.5 Bausch Health Companies Key News
7.5 Apotex
  7.5.1 Apotex Corporate Summary
  7.5.2 Apotex Business Overview
  7.5.3 Apotex Renal Drugs Major Product Offerings
  7.5.4 Apotex Renal Drugs Revenue in Global Market (2017-2022)
  7.5.5 Apotex Key News
7.6 Cardinal Health
  7.6.1 Cardinal Health Corporate Summary
  7.6.2 Cardinal Health Business Overview
  7.6.3 Cardinal Health Renal Drugs Major Product Offerings
  7.6.4 Cardinal Health Renal Drugs Revenue in Global Market (2017-2022)
  7.6.5 Cardinal Health Key News
7.7 Fresenius
  7.7.1 Fresenius Corporate Summary
  7.7.2 Fresenius Business Overview
  7.7.3 Fresenius Renal Drugs Major Product Offerings
  7.7.4 Fresenius Renal Drugs Revenue in Global Market (2017-2022)
  7.7.5 Fresenius Key News
7.8 Dava Pharmaceuticals
  7.8.1 Dava Pharmaceuticals Corporate Summary
  7.8.2 Dava Pharmaceuticals Business Overview
  7.8.3 Dava Pharmaceuticals Renal Drugs Major Product Offerings
  7.8.4 Dava Pharmaceuticals Renal Drugs Revenue in Global Market (2017-2022)
  7.8.5 Dava Pharmaceuticals Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Renal Drugs Market Opportunities & Trends in Global Market
Table 2. Renal Drugs Market Drivers in Global Market
Table 3. Renal Drugs Market Restraints in Global Market
Table 4. Key Players of Renal Drugs in Global Market
Table 5. Top Renal Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Renal Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Renal Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Renal Drugs Product Type
Table 9. List of Global Tier 1 Renal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Renal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Renal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Renal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Renal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Renal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Renal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Renal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Renal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Renal Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Renal Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Renal Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Renal Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Renal Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Renal Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Renal Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Renal Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Renal Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Renal Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Renal Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Renal Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Mylan Corporate Summary
Table 31. Mylan Renal Drugs Product Offerings
Table 32. Mylan Renal Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Roche Holding Corporate Summary
Table 34. Roche Holding Renal Drugs Product Offerings
Table 35. Roche Holding Renal Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Endo International Corporate Summary
Table 37. Endo International Renal Drugs Product Offerings
Table 38. Endo International Renal Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Bausch Health Companies Corporate Summary
Table 40. Bausch Health Companies Renal Drugs Product Offerings
Table 41. Bausch Health Companies Renal Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Apotex Corporate Summary
Table 43. Apotex Renal Drugs Product Offerings
Table 44. Apotex Renal Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Cardinal Health Corporate Summary
Table 46. Cardinal Health Renal Drugs Product Offerings
Table 47. Cardinal Health Renal Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Fresenius Corporate Summary
Table 49. Fresenius Renal Drugs Product Offerings
Table 50. Fresenius Renal Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Dava Pharmaceuticals Corporate Summary
Table 52. Dava Pharmaceuticals Renal Drugs Product Offerings
Table 53. Dava Pharmaceuticals Renal Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Renal Drugs Segment by Type in 2021
Figure 2. Renal Drugs Segment by Application in 2021
Figure 3. Global Renal Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Renal Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Renal Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Renal Drugs Revenue in 2021
Figure 8. By Type - Global Renal Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Renal Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Renal Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Renal Drugs Revenue Market Share, 2017-2028
Figure 12. US Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Renal Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Renal Drugs Revenue Market Share, 2017-2028
Figure 24. China Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Renal Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Renal Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Renal Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Mylan Renal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Holding Renal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Endo International Renal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bausch Health Companies Renal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Apotex Renal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cardinal Health Renal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Fresenius Renal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Dava Pharmaceuticals Renal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)